Changes in duodenal enteroendocrine cells in patients with irritable bowel syndrome following dietary guidance.

PubWeight™: 0.76‹?›

🔗 View Article (PMID 28737477)

Published in Exp Biol Med (Maywood) on March 17, 2017

Authors

Tarek Mazzawi1,2, Magdy El-Salhy1,2,3

Author Affiliations

1: 1 Division of Gastroenterology, Department of Clinical Medicine, University of Bergen, Bergen 5021, Norway.
2: 2 National Centre for Functional Gastrointestinal Disorders, Division of Gastroenterology, Department of Medicine, Haukeland University Hospital-Helse Bergen, Bergen 5021, Norway.
3: 3 Division of Gastroenterology, Department of Medicine, Stord Hospital-Helse Fonna, Stord 5416, Norway.

Associated clinical trials:

Low FODMAPs Diet vs. Specific Dietary Advice in Patients With IBS Diarrheal Variant (DIETSINIBS) | NCT03423069

Articles cited by this

A diet low in FODMAPs reduces symptoms of irritable bowel syndrome. Gastroenterology (2013) 8.37

The chromogranin-secretogranin family. N Engl J Med (2003) 4.28

Quality of life in persons with irritable bowel syndrome: development and validation of a new measure. Dig Dis Sci (1998) 3.74

Further validation of the IBS-QOL: a disease-specific quality-of-life questionnaire. Am J Gastroenterol (2000) 2.95

Cholecystokinin bioactivity in human plasma. Molecular forms, responses to feeding, and relationship to gallbladder contraction. J Clin Invest (1985) 2.64

Validity of a new food frequency questionnaire for pregnant women in the Norwegian Mother and Child Cohort Study (MoBa). Matern Child Nutr (2008) 2.15

Food-related gastrointestinal symptoms in the irritable bowel syndrome. Digestion (2001) 2.05

Inhibition of histamine-, pentagastrin-, and insulin-stimulated canine gastric secretion by pure "gastric inhibitory polypeptide". Gastroenterology (1972) 2.05

Methodological challenges when monitoring the diet of pregnant women in a large study: experiences from the Norwegian Mother and Child Cohort Study (MoBa). Matern Child Nutr (2008) 2.02

Enteroendocrine cells: a site of 'taste' in gastrointestinal chemosensing. Curr Opin Endocrinol Diabetes Obes (2008) 1.94

Statistical approaches for assessing the relative validity of a food-frequency questionnaire: use of correlation coefficients and the kappa statistic. Public Health Nutr (2003) 1.88

5-Hydroxytryptamine (serotonin) in the gastrointestinal tract. Curr Opin Endocrinol Diabetes Obes (2013) 1.79

Synaptophysin and chromogranins/secretogranins--widespread constituents of distinct types of neuroendocrine vesicles and new tools in tumor diagnosis. Virchows Arch B Cell Pathol Incl Mol Pathol (1989) 1.73

Somatostatin suppresses secretin and pancreatic exocrine secretion. Science (1975) 1.45

Molecular mechanisms underlying nutrient-stimulated incretin secretion. Expert Rev Mol Med (2010) 1.44

Perceived food intolerance in subjects with irritable bowel syndrome-- etiology, prevalence and consequences. Eur J Clin Nutr (2006) 1.39

Release of cholecystokinin in man: correlation of blood levels with gallbladder contraction. Ann Surg (1981) 1.34

Irritable bowel syndrome: diagnosis and pathogenesis. World J Gastroenterol (2012) 1.32

Chromogranin A: its role in endocrine function and as an endocrine and neuroendocrine tumor marker. Endocr Rev (1991) 1.29

Quality of life in functional dyspepsia: responsiveness of the Nepean Dyspepsia Index and development of a new 10-item short form. Aliment Pharmacol Ther (2001) 1.25

Intestinal sensing of nutrients. Handb Exp Pharmacol (2012) 1.20

Chromogranin A as a possible tool in the diagnosis of irritable bowel syndrome. Scand J Gastroenterol (2010) 1.17

Cholecystokinin suppresses food intake by inhibiting gastric emptying. Am J Physiol (1982) 1.15

Nutrient Tasting and Signaling Mechanisms in the Gut III. Endocrine cell recognition of luminal nutrients. Am J Physiol (1999) 1.14

Molecular mechanisms of enteroendocrine differentiation. Ann N Y Acad Sci (1998) 1.09

Abnormal rectal endocrine cells in patients with irritable bowel syndrome. Regul Pept (2013) 1.07

Mindfulness-based stress reduction for the treatment of irritable bowel syndrome symptoms: a randomized wait-list controlled trial. Int J Behav Med (2013) 1.07

Evaluation of the Birmingham IBS symptom questionnaire. BMC Gastroenterol (2008) 1.06

Chromogranin A promotes peptide hormone sorting to mobile granules in constitutively and regulated secreting cells: role of conserved N- and C-terminal peptides. J Biol Chem (2009) 1.05

Plasticity in serotonin control mechanisms in the gut. Curr Opin Pharmacol (2003) 1.05

Fructan and free fructose content of common Australian vegetables and fruit. J Agric Food Chem (2007) 1.03

Quantification of fructans, galacto-oligosacharides and other short-chain carbohydrates in processed grains and cereals. J Hum Nutr Diet (2011) 1.02

Nutrient sensing in the gastrointestinal tract: possible role for nutrient transporters. J Physiol Biochem (2008) 1.01

Is irritable bowel syndrome an organic disorder? World J Gastroenterol (2014) 1.01

Measurement of short-chain carbohydrates in common Australian vegetables and fruits by high-performance liquid chromatography (HPLC). J Agric Food Chem (2009) 0.99

Ageing and endocrine cells of human duodenum. Mech Ageing Dev (1999) 0.99

Effects of glucose and meal ingestion on incretin secretion in Japanese subjects with normal glucose tolerance. J Diabetes Investig (2012) 0.99

Diet and effects of diet management on quality of life and symptoms in patients with irritable bowel syndrome. Mol Med Rep (2012) 0.99

5-HT receptor subtypes outside the central nervous system. Roles in the physiology of the gut. Neuropsychopharmacology (1991) 0.98

Secretin as a neurohypophysial factor regulating body water homeostasis. Proc Natl Acad Sci U S A (2009) 0.97

The role of diet in the pathogenesis and management of irritable bowel syndrome (Review). Int J Mol Med (2012) 0.97

Abnormal small-intestinal endocrine cells in patients with irritable bowel syndrome. Dig Dis Sci (2010) 0.96

Low densities of serotonin and peptide YY cells in the colon of patients with irritable bowel syndrome. Dig Dis Sci (2011) 0.96

Subpopulations of gastric myenteric neurons are differentially activated via distinct serotonin receptors: projection, neurochemical coding, and functional implications. J Neurosci (1997) 0.95

A randomized controlled trial of imipramine in patients with irritable bowel syndrome. World J Gastroenterol (2009) 0.95

Multiple actions of secretin in the human body. Int Rev Cytol (2008) 0.95

Effects of dietary guidance on the symptoms, quality of life and habitual dietary intake of patients with irritable bowel syndrome. Mol Med Rep (2013) 0.94

Endocrine cells in the ileum of patients with irritable bowel syndrome. World J Gastroenterol (2014) 0.93

Cellular kinetics of gastrointestinal mucosa, with special reference to gut endocrine cells. Arch Histol Jpn (1983) 0.92

Secretin and body fluid homeostasis. Kidney Int (2010) 0.91

Quality of life in patients with subjective food hypersensitivity: applicability of the 10-item short form of the Nepean Dyspepsia Index. Dig Dis Sci (2004) 0.90

Irritable bowel syndrome: recent developments in diagnosis, pathophysiology, and treatment. Expert Rev Gastroenterol Hepatol (2014) 0.89

Overview of incretin hormones. Horm Metab Res (2005) 0.88

Cholecystokinin suppresses food intake by a nonendocrine mechanism in rats. Am J Physiol (1994) 0.88

Ghrelin in patients with irritable bowel syndrome. Int J Mol Med (2009) 0.88

[Determination of placebo effect in irritable bowel syndrome]. Dtsch Med Wochenschr (2005) 0.87

Fatty acid-binding protein 5 regulates diet-induced obesity via GIP secretion from enteroendocrine K cells in response to fat ingestion. Am J Physiol Endocrinol Metab (2015) 0.85

Interaction between ingested nutrients and gut endocrine cells in patients with irritable bowel syndrome (review). Int J Mol Med (2014) 0.85

Importance of CCK-A receptor for gallbladder contraction and pancreatic secretion: a study in CCK-A receptor knockout mice. Jpn J Physiol (2001) 0.85

Suppression of gastrin release and gastric secretion by gastric inhibitory polypeptide (GIP) and vasoactive intestinal polypeptide (VIP). Ann Surg (1976) 0.84

Endocrine cells in the oxyntic mucosa of the stomach in patients with irritable bowel syndrome. World J Gastrointest Endosc (2014) 0.84

Increased chromogranin a cell density in the large intestine of patients with irritable bowel syndrome after receiving dietary guidance. Gastroenterol Res Pract (2015) 0.84

Recent developments in the pathophysiology of irritable bowel syndrome. World J Gastroenterol (2015) 0.84

Increased gastric chromogranin A cell density following changes to diets of patients with irritable bowel syndrome. Mol Med Rep (2014) 0.83

Diet in irritable bowel syndrome. Nutr J (2015) 0.81

Secretin-induced gastric relaxation is mediated by vasoactive intestinal polypeptide and prostaglandin pathways. Neurogastroenterol Motil (2009) 0.81

Dietary guidance normalizes large intestinal endocrine cell densities in patients with irritable bowel syndrome. Eur J Clin Nutr (2015) 0.81

Effect of dietary management on the gastric endocrine cells in patients with irritable bowel syndrome. Eur J Clin Nutr (2014) 0.80

Role of secretin and CCK in the stimulation of pancreatic secretion in conscious dogs. Effects of atropine and somatostatin. Int J Pancreatol (1987) 0.80

Reduction in duodenal endocrine cells in irritable bowel syndrome is associated with stem cell abnormalities. World J Gastroenterol (2015) 0.79

Effect of the secretin family of peptides on gastric emptying and small intestinal transit in rats. Peptides (1988) 0.79

Changes in small intestinal chromogranin A-immunoreactive cell densities in patients with irritable bowel syndrome after receiving dietary guidance. Int J Mol Med (2016) 0.78

Comparative effects of CCK-8 on feeding, sham feeding, and exocrine pancreatic secretion in rats. Am J Physiol (1986) 0.76

Dietary guidance and ileal enteroendocrine cells in patients with irritable bowel syndrome. Exp Ther Med (2016) 0.75